The fast-food chain’s shareholders voted to re-elect all 10 directors, beating back a “vote no” effort on Chairman David ...

The Matrix 5 finally gets a promising update 5 years after the last film in the franchise hit theaters. See what ...

Researchers sought to determine the acute cardiovascular effects of amphetamine-dextroamphetamine use in healthy people free of ADHD. Study volunteers showed increases in blood pressure, heart rate, ...

Eli Lilly’s new oral pill, orforglipron, led to up to 8% weight loss in clinical trials, outperforming existing oral ...

A new international study has found encouraging news for people living with both diabetes and heart failure. Researchers ...

A new pill could help patients lose more weight and gain better control of their blood sugar levels than current weight loss ...

Eli Lilly released new data on its oral pill, orforglipron, Thursday, showing it's almost as good as Ozempic. The pill may be available this spring.

The telehealth company posted Q4 earnings per share of $0.08, topping analyst estimates of $0.05. Revenue rose to $617.8 million, compared with consensus expectations of $618.7 million. The results ...

Wegovy generated DKK 79.1 billion in net revenues for Novo Nordisk in 2025, a 35.9% increase year-on-year. Learn why NVO stock is a strong buy.

Presidents' Day is here, and you can steal some nice deals like the Samsung Galaxy Book 4 laptop for $400 off and a 23% discount on the JBL Clip 4 speaker.

Hims & Hers Health launched a cheaper, compounded version of the new Wegovy pill in a move that reignites its competition with Novo Nordisk in the U.S. obesity-drug market. Shares of of Hims & Hers ...